Trial Profile
AUTOLOGOUS BONE MARROW TRANSPLANTATION USING C-MYB (LR-3001) [G-4460] ANTISENSE OLIGODEOXYNUCLEOTIDE TREATED BONE MARROW IN CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC OR ACCELERATED PHASE.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Mar 2023
Price :
$35
*
At a glance
- Drugs G 4460 (Primary) ; Busulfan; Cyclophosphamide
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions
- 18 Aug 2008 New trial record.